This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Fanny O'Brien: Innovator in Myasthenia Gravis Treatment
Introduction
Fanny O'Brien is a notable inventor based in Norwell, MA (US). She has made significant contributions to the field of medical treatment, particularly in addressing refractory generalized myasthenia gravis. Her innovative approach has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Fanny O'Brien holds 1 patent for her work titled "Methods for treatment of refractory generalized myasthenia gravis." This patent discloses methods of treating myasthenia gravis (MG) in a subject in need thereof by administering a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody.
Career Highlights
Fanny O'Brien is currently employed at Alexion Pharmaceuticals, Inc., where she continues to develop innovative treatments. Her work is crucial in advancing therapeutic options for patients with myasthenia gravis.
Collaborations
Fanny collaborates with talented coworkers, including Camille Bedrosian and Jing Jing Wang. Their combined expertise contributes to the success of their projects and the advancement of medical treatments.
Conclusion
Fanny O'Brien's contributions to the treatment of myasthenia gravis exemplify the impact of innovation in medicine. Her work not only highlights her dedication as an inventor but also underscores the importance of collaboration in achieving significant advancements in healthcare.